Document Classification

Section Type: RESULTS

Text: In both studies, we noted improvements in trough FEV1 on day 169 for both doses of UMEC plus VI compared with TIO monotherapy (study 1, UMEC 125 g plus VI 25 g : 0088 L [95 % CI 0036 to 0140 ; p = 00010] ; study 1, UMEC 625 g plus VI 25 g : 0090 L [0039 to 0141 ; p = 00006] ; study 2, UMEC 125 g plus VI 25 g : 0074 L [0025 to 0123 ; p = 00031] ; study 2, UMEC 625 g plus VI 25 g : 0060 L [0010 to 0109 ; nominal p = 00182]).